ARCEDI Expands Prenatal Screening to Cystic Fibrosis as GENIUS Study Begins Recruitment
PRESS RELEASE New cell-based screening option and ongoing clinical research advance the path towards more informed, personalized pregnancy care. Denmark, November 12, 2026 – ARCEDI Biotech announces the launch of cell-based prenatal screening for cystic fibrosis (CF) in Denmark, extending its EVITA TEST COMPLETE offering beyond chromosomal abnormalities into selected single-gene conditions. The launch comes …
ARCEDI Expands Prenatal Screening to Cystic Fibrosis as GENIUS Study Begins Recruitment Read More »








